Abstract
Background
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disorder and shows high variability in genetic heterogeneity and phenotypic characteristics. The genetic etiology responsible for HCM in many individuals remains unclear.
Objective
This instigation was sought to identify novel genetic determinants for familial hypertrophic cardiomyopathy.
Methods
Six unrelated Chinese families with HCM were studied. For each of the 13 established HCM‐susceptibility genes, 3 to 5 microsatellite markers were selected to perform genotyping and haplotype analysis. The linked genes were sequenced.
Results
Haplotype analyses on candidate genetic loci revealed cosegregation of the gene β‐myosin heavy chain (MYH7) with HCM in a single family. A novel double heterozygous missense mutation of Ala26Val plus Arg719Trp in MYH7 was subsequently identified by sequencing in this family and was associated with a severe phenotype of HCM.
Conclusion
The novel double mutation of Ala26Val plus Arg719Trp in MYH7 identified in a Chinese family highlights the remarkable genetic heterogeneity of HCM, which provides important information for genetic counseling, accurate diagnosis, prognostic evaluation, and appropriate clinical management. Copyright © 2009 Wiley Periodicals, Inc.
Full Text
The Full Text of this article is available as a PDF (898.9 KB).
References
- 1. Hughes SE, McKenna WJ. New insights into the pathology of inherited cardiomyopathy. Heart 2005; 91: 257–264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Maron BJ, Gardin JM., Flack JM., Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995; 92: 785–789. [DOI] [PubMed] [Google Scholar]
- 3. Jarcho JA, McKenna W, Pare JA, et al. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med 1989; 321: 1372–1378. [DOI] [PubMed] [Google Scholar]
- 4. Woo A, Rakowski H, Liew JC, et al. Mutations of the β myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis. Heart 2003; 89: 1179–1185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Tsoutsman T, Lam L, Semsarian C. Genes, calcium and modifying factors in hypertrophic cardiomyopathy. Clin Exp Pharmacol Physiol 2006; 33: 139–145. [DOI] [PubMed] [Google Scholar]
- 6. Laforet P, Richard P, Said MA, et al. A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis. Neuromuscul Disord 2006; 16: 178–182. [DOI] [PubMed] [Google Scholar]
- 7. Prasad GN, Vanniarajan A, Emmanuel C, Cherian KM, Singh L, Thangaraj K. Novel mitochondrial DNA mutations in a rare variety of hypertrophic cardiomyopathy. Int J Cardiol 2006; 109: 432–433. [DOI] [PubMed] [Google Scholar]
- 8. Charron P, Dubourg O, Desnos M, et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation 1997; 96: 214–219. [DOI] [PubMed] [Google Scholar]
- 9. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and diastolic filling abnormalities in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990; 15: 808–813. [DOI] [PubMed] [Google Scholar]
- 10. Maron BJ, Gottdiener JS, Epstein S. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 1981; 48: 418–428. [DOI] [PubMed] [Google Scholar]
- 11. Dib C, Fauré S, Fizames C, et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 1996; 80: 152–154. [DOI] [PubMed] [Google Scholar]
- 12. Redwood CS, Moolman‐Smook JC, Watkins H. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovac Res 1999; 44: 20–36. [DOI] [PubMed] [Google Scholar]
- 13. Arai S, Matsuoka R, Hirayama K, et al. Missense mutation of the β ‐cardiac myosin heavy‐chain gene in hypertrophic cardiomyopathy. Am J Med Genet 1995; 58(3): 267–276. [DOI] [PubMed] [Google Scholar]
- 14. Liu SX, Hu SJ, Sun J, et al. Characteristics of the β myosin heavy chain gene Ala26Val mutation in a Chinese family with hypertrophic cardiomyopathy. Eur J Intern Med 2005; 16: 328–333. [DOI] [PubMed] [Google Scholar]
- 15. Anan R, Greve G, Thierfelder L, et al. Prognostic implications of novel β cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 1994; 93: 280–285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Jeschke B, Uhl K, Weist B, et al. A high risk phenotype of hypertrophic cardiomyopathy associated with a double genotype of two mutated β ‐myosin heavy chain genes. Hum Genet 1998; 102: 299–304. [DOI] [PubMed] [Google Scholar]
- 17. Gimelbrant A, Hutchinson JN, Thompson BR, Chess A. Widespread monoallelic expression on human autosomes. Science 2007; 318: 1136–1140. [DOI] [PubMed] [Google Scholar]
- 18. Alcalai R, Seidman JG., Seidman CE. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol 2008; 19: 104–110. [DOI] [PubMed] [Google Scholar]